Source MS Society: We’re investing over £2 million in the Edinburgh Centre for MS Research, so that they can continue their world-class research for a further five years. We set up the Edinburgh Centre (formerly known as the Edinburgh Centre for Translational Research) in 2007 with the generous support of the Volant Trust. The overall… Read more »
Posts Categorized: MS News
MS Awareness Week: 7 Things People With Multiple Sclerosis Want You To Know
Source HUFFPOST LIFESTYLE: There are currently around 100,000 people with multiple sclerosis in the UK. With this in mind, it’s perhaps surprising how little the majority of people know about the disease. So, to co-inside with MS Awareness Week, here are seven things people with MS want you to know: Read on.
Phenytoin has neuroprotective effect suggests study
Source MS Trust: Research suggests that phenytoin, a drug used to treat seizures, may protect nerves from MS. The phase II study at University College London involved 86 people with optic neuritis – a symptom associated with MS in which the covering of the optic nerve is damaged. Participants took either phenytoin or placebo for… Read more »
Two potential myelin repair treatments identified
Source MS Society: A new early stage study has identified two existing drugs that could have the potential to be developed into myelin repair therapies for people with MS. Researchers in Ohio screened the US National Institute of Health’s drug ‘library’ for compounds that could have the potential to stimulate stem cells already in the… Read more »
Election 2015: What are the parties pledging?
Source MS Society: With the general election just weeks away, most of the larger political parties have now published their manifestos. But what are they promising on some of the key issues for people affected by MS? We look at how the Conservative, Green, Labour, Liberal Democrat and UK Independence Party manifestos stack up on… Read more »
Listen again to Oxfords ground-breaking trial aiming to find a cure for MS
Howard Bentham of BBC Radio Oxford finds out about Oxford’s ground-breaking trial aiming to find a cure for multiple sclerosis. Listen again here.
Encouraging signs of myelin repair in optic neuritis drug trial
Source MS Trust:In a clinical trial of anti-LINGO-1, people with optic neuritis who took the new drug had improved nerve signals between the eye and the brain. A phase II clinical trial called RENEW tested a drug called BIIB033, which is anti-LINGO-1 agent, against placebo in 82 people with acute optic neuritis. Participants received a… Read more »
£1.1m study to reduce cognitive problems in people with MS
Source EurekAlert: Experts in Nottingham are leading a major new study into how people with multiple sclerosis (MS) could overcome problems with attention and memory associated to their condition. The Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis (CRAMMS) trial will evaluate the effectiveness of new strategies to improve and compensate for… Read more »
Positive interim results from major UK study on MS drugs
Source MS Trust:Results of the analysis of the 6 year data of the Department of Health (DH) MS Risk-sharing Scheme (RSS), published in the Lancet Neurology today, show that the disease modifying drugs Avonex, Betaferon, Copaxone and Rebif are cost effective and are clinically effective in reducing the progression of the disease in people with… Read more »
MS drug ‘may already be out there’
Source BBC: Depression and heart-disease drugs are to be tested in a trial to find treatments for Multiple Sclerosis (MS) from existing medicines. There are currently no treatments in the secondary progressive stage of the debilitating disease. More than 400 people will take part in the trial at University College London and the University of… Read more »
